Targeting CDK9 for Anti-Cancer Therapeutics

SIMPLE SUMMARY: CDK9, in combination with Cyclin T1, is one of the major regulators of RNA Polymerase II mediated productive transcription of critical genes in any cell. The activity of CDK9 is significantly up-regulated in a wide variety of cancer entities, to aid in the overexpression of genes res...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Ranadip, Becker, Sven, Strebhardt, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124690/
https://www.ncbi.nlm.nih.gov/pubmed/34062779
http://dx.doi.org/10.3390/cancers13092181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124690/
https://www.ncbi.nlm.nih.gov/pubmed/34062779
http://dx.doi.org/10.3390/cancers13092181

Ejemplares similares